Acquisition2025-03-11confirmed
Tempus AI, Inc. × Deep 6 AI
Tempus AI, a major player in precision medicine and AI, acquired Deep 6 AI to enhance its clinical trial matching capabilities. [34, 35] The acquisition adds Deep 6's network of over 750 provider sites and more than 30 million patients to Tempus's ecosystem. [40, 43] Financial terms of the deal were not disclosed. [35]
Price paid
—
Not disclosed
Losing bid
—
Per unit
—
no meaningful ratio
The asset
An AI-powered precision research platform that matches patients to clinical trials by mining real-time structured and unstructured electronic medical record (EMR) data. [34, 40]
- 30M patients in connected network
The record
- Seller status
- Going concern
- Sector
- AI clinical trial recruitment
- Modalities
- text, medical records, clinical trial data
- Jurisdiction
- US
- Personal data
- The software masks protected health information and uses AI to interpret de-identified clinical data to match patients with trials, operating within HIPAA guidelines. [60, 76]
What it means if you hold data
This acquisition combines Tempus's vast library of multimodal data with Deep 6's specialized AI for patient recruitment, aiming to create a more powerful, end-to-end system for accelerating clinical research and patient access to trials. [34, 40]